TickerFactsScreenerDevelopers

ZEVRA THERAPEUTICS, INC. (ZVRA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2015: -$20.27M2016: -$29.77M2017: -$33.10M2018: -$54.20M2019: -$23.74M2020: -$1.94M2021: $10.44M2022: -$18.72M2023: -$33.53M2024: -$69.67M2025: -$1.60M-$1.60M
2015Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$1.60M+97.7%
2024-$69.67M-107.7%
2023-$33.53M-79.2%
2022-$18.72M-279.3%
2021$10.44M+638.4%
2020-$1.94M+91.8%
2019-$23.74M+56.2%
2018-$54.20M-63.8%
2017-$33.10M-11.2%
2016-$29.77M-46.9%
2015-$20.27M—